RESEARCH TRIANGLE PARK, NC, Clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), announced completion of a $4.85 million financing. Existing investors Perseus Soros Biopharmaceutical Fund, L Capital Partners, Pappas Ventures and Omega Funds all participated in the financing.
Read More